Close

Glyphic Biotechnologies

Next generation protein sequencing
Founders:

Joshua Yang

Co-Founder / CEO, Glyphic Biotechnologies

Daniel Estandian

Co-Founder / CTO, Glyphic Biotechnologies
About

Glyphic Bio is transforming the field of proteomics by making it possible to sequence all 20 amino acids with single-molecule precision. While DNA sequencing revolutionized biomedical science by decoding the human genome, it only tells part of the story. Proteins—what they’re made of and how they’re modified—are the real keys to understanding how the human body works. Glyphic’s cutting-edge platform is opening up this new frontier, enabling breakthroughs in drug development, diagnostics, and human biology. By unlocking the secrets of the human proteome, Glyphic is paving the way for game-changing innovations in healthcare, biotechnology, and beyond.

No items found.
Why we're excited

Latest news from Glyphic Biotechnologies

No items found.